Rahele Mohseni
Medical · Charlotte, NCNPI 1619244241
Payments from drug & device makers
Across 676 payments — averaging $18.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$2K
- AstraZeneca$1K
- Boehringer Ingelheim$1K
- AbbVie$1K
- Amgen$874
- Lilly USA, LLC$788
- plus $6K from 36 others
What the payments were for
- Food & beverage$12,07698%
- Education$2892%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$12,365 in reported general payments places this provider in the 95th percentile of 878 medical providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RybelsusSemaglutide | 82 | $118,076 |
| JardianceEmpagliflozin | 110 | $108,514 |
| FarxigaDapagliflozin Propanediol | 106 | $95,038 |
| MounjaroTirzepatide | 65 | $84,580 |
| EliquisApixaban | 67 | $62,528 |
| ProliaDenosumab | 35 | $61,223 |
| MyrbetriqMirabegron | 81 | $57,344 |
| OzempicSemaglutide | 37 | $57,205 |
| XareltoRivaroxaban | 50 | $49,238 |
| Repatha SureclickEvolocumab | 40 | $38,316 |
| KerendiaFinerenone | 32 | $33,124 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 14 | $21,739 |
| VraylarCariprazine Hcl | 11 | $18,433 |
| Breo ElliptaFluticasone/Vilanterol | 21 | $16,595 |
| VascepaIcosapent Ethyl | 35 | $15,783 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskRybelsus, Ozempic | $1,628 | $175,281119 claims |
| Boehringer IngelheimJardiance, Synjardy Xr | $1,054 | $130,252124 claims |
| AstraZenecaFarxiga | $1,384 | $95,038106 claims |
| Lilly USA, LLCMounjaro | $788 | $84,58065 claims |
| PfizerEliquis, Paxlovid | $614 | $63,95786 claims |
| AmgenProlia | $874 | $61,22335 claims |
| Astellas Pharma US IncMyrbetriq | $449 | $57,34481 claims |
| Johnson & JohnsonXarelto | $637 | $49,23850 claims |
| BayerKerendia | $577 | $33,12432 claims |
| AbbVieVraylar, Synthroid | $1,012 | $21,56663 claims |
| GSKBreo Ellipta | $143 | $16,59521 claims |
| MerckJanuvia | $114 | $10,55319 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 878 medical providers in North Carolina.
Other medical in Charlotte
- Joel ThompsonCharlotte$269K
- Rochelle LunaCharlotte$19K
- Dana DorenfeldCharlotte$17K
- Keri SquittieriCharlotte$17K
- Tonya FraserCharlotte$16K
- Lisa MatugaCharlotte$15K
- Claire HolmquistCharlotte$14K
- Tyler HyslepCharlotte$13K
- Rachelle CroninCharlotte$10K
- Arica SargentCharlotte$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.